Cartesian Therapeutics Inc Sustainability Reports
Cartesian Therapeutics, Inc. is a clinical-stage biotechnology company pioneering the development of mRNA-engineered cell therapies. The company focuses primarily on developing therapeutic options for patients with autoimmune diseases.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 529900NMN0LACZOL7C43
FIGI: BBG001V0FQQ0
9 reports from 2016 to 2024
